Annual EBITDA
$758.83M$264.97M-25.88%
Summary
- Current Value
- As of today, RDY annual EBITDA is $758.83M, down -25.88% on
- Historical Performance
- RDY annual EBITDA is down -5.96% over the past 3 years, up +25.67% over the past 5 years
- All-Time High Comparison
- RDY annual EBITDA is currently -25.88% below its historical high of $1.02B set on
- 3-Year Low Comparison
- RDY annual EBITDA is at its 3-year low
- Sector Comparison
- RDY annual EBITDA is higher than 91.97% of companies in Healthcare sector
EBITDA Chart
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual EBITDA | $758.83M | -25.9% | -6.0% | +25.7% | +120.5% | |
| Quarterly EBITDA | $88.76M | -64.8% | -64.4% | -27.8% | +3.3% | |
| TTM EBITDA | $603.67M | -40.8% | -35.1% | +4.2% | +69.9% | |
| Price | $11.77 | -20.3% | -14.5% | -7.0% | +65.0% | |
| PE Ratio | 26.45 | +43.2% | +33.6% | -41.6% | +11.5% | |
| Annual Revenue | $3.80B | -1.3% | +24.3% | +48.8% | +131.7% | |
| Annual EPS | $0.58 | -27.4% | -13.7% | +108.5% | +103.9% | |
| $525.62M | -36.1% | -19.1% | +21.8% | +107.8% | ||
| Annual Net Income | $480.61M | -29.0% | -14.3% | +107.0% | +98.2% |
EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $1.02B | -25.9% | |
| 5Y | $1.02B | -25.9% | |
| All | $1.02B | -25.9% |
EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | $758.83M | at low | |
| 5Y | $603.81M | N/A | +25.7% |
| All | $11.77M | +6344.8% |
EBITDA History
FAQ
What is the current annual EBITDA of RDY?
As of today, RDY annual EBITDA is $758.83M
What is 1-year change in RDY annual EBITDA?
RDY annual EBITDA is down -25.88% year-over-year
What is 3-year change in RDY annual EBITDA?
RDY annual EBITDA is down -5.96% over the past 3 years
How far is RDY annual EBITDA from its all-time high?
RDY annual EBITDA is currently -25.88% below its historical high of $1.02B set on March 31, 2025
How does RDY annual EBITDA rank versus sector peers?
RDY annual EBITDA is higher than 91.97% of companies in Healthcare sector
When is RDY next annual earnings release?
As of today, the next annual earnings release for RDY has not been scheduled
EBITDA Formula
EBITDA = Net Income + + +
Quarterly EBITDA
$88.76M$22.76M+34.49%
Summary
- Current Value
- As of today, RDY quarterly EBITDA is $88.76M, up +34.49% on
- Historical Performance
- RDY quarterly EBITDA is down -64.84% year-over-year, down -64.43% over the past 3 years
- All-Time High Comparison
- RDY quarterly EBITDA is currently -67.51% below its historical high of $273.22M set on
- 3-Year Low Comparison
- RDY quarterly EBITDA is +34.49% above its 3-year low of $66.00M reached on
- Sector Comparison
- RDY quarterly EBITDA is higher than 88.45% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly EBITDA | $88.76M | +34.5% | -64.8% | -64.4% | -27.8% | |
| Annual EBITDA | $758.83M | – | -25.9% | -6.0% | +25.7% | |
| TTM EBITDA | $603.67M | -21.3% | -40.8% | -35.1% | +4.2% | |
| Price | $11.77 | -14.3% | -20.3% | -14.5% | -7.0% | |
| PE Ratio | 26.45 | +13.1% | +43.2% | +33.6% | -41.6% | |
| Quarterly Revenue | $852.30M | +3.8% | -14.6% | +4.0% | +27.8% | |
| Quarterly EPS | $0.06 | +95.1% | -71.7% | -72.6% | -39.6% | |
| $31.20M | +512.9% | -84.2% | -84.9% | -62.7% | ||
| Quarterly Net Income | $45.92M | +90.6% | -72.1% | -73.1% | -40.7% |
Quarterly EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $252.46M | N/A | -64.8% |
| 3Y | $273.22M | -67.5% | |
| 5Y | $273.22M | -67.5% | |
| All | $273.22M | -67.5% |
Quarterly EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $66.00M | +34.5% | |
| 3Y | $66.00M | +34.5% | |
| 5Y | $66.00M | +34.5% | |
| All | $1.46M | +5963.0% |
Quarterly EBITDA History
FAQ
What is the current quarterly EBITDA of RDY?
As of today, RDY quarterly EBITDA is $88.76M
What is RDY quarterly EBITDA most recent change?
RDY quarterly EBITDA was up +34.49% on June 30, 2026
What is 1-year change in RDY quarterly EBITDA?
RDY quarterly EBITDA is down -64.84% year-over-year
How far is RDY quarterly EBITDA from its all-time high?
RDY quarterly EBITDA is currently -67.51% below its historical high of $273.22M set on December 31, 2024
How does RDY quarterly EBITDA rank versus sector peers?
RDY quarterly EBITDA is higher than 88.45% of companies in Healthcare sector
When is RDY next earnings release?
The next earnings release for RDY is on
EBITDA Formula
EBITDA = Net Income + + +
TTM EBITDA
$603.67M$163.70M-21.33%
Summary
- Current Value
- As of today, RDY TTM EBITDA is $603.67M, down -21.33% on
- Historical Performance
- RDY TTM EBITDA is down -40.79% year-over-year, down -35.12% over the past 3 years
- All-Time High Comparison
- RDY TTM EBITDA is currently -40.99% below its historical high of $1.02B set on
- 3-Year Low Comparison
- RDY TTM EBITDA is at its 3-year low
- Sector Comparison
- RDY TTM EBITDA is higher than 90.99% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM EBITDA | $603.67M | -21.3% | -40.8% | -35.1% | +4.2% | |
| Annual EBITDA | $758.83M | – | -25.9% | -6.0% | +25.7% | |
| Quarterly EBITDA | $88.76M | +34.5% | -64.8% | -64.4% | -27.8% | |
| Price | $11.77 | -14.3% | -20.3% | -14.5% | -7.0% | |
| PE Ratio | 26.45 | +13.1% | +43.2% | +33.6% | -41.6% | |
| TTM Revenue | $3.66B | -3.8% | -6.8% | +14.5% | +38.6% | |
| TTM EPS | $0.45 | -24.2% | -44.3% | -36.0% | +59.3% | |
| $368.07M | -31.0% | -54.5% | -52.2% | -9.9% | ||
| TTM Net Income | $366.97M | -24.4% | -45.6% | -36.5% | +58.0% |
TTM EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $1.02B | N/A | -40.8% |
| 3Y | $1.02B | -41.0% | |
| 5Y | $1.02B | -41.0% | |
| All | $1.02B | -41.0% |
TTM EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $603.67M | at low | |
| 3Y | $603.67M | at low | |
| 5Y | $579.16M | N/A | +4.2% |
| All | $15.84M | +3710.2% |
TTM EBITDA History
FAQ
What is the current TTM EBITDA of RDY?
As of today, RDY TTM EBITDA is $603.67M
What is RDY TTM EBITDA most recent change?
RDY TTM EBITDA was down -21.33% on June 30, 2026
What is 1-year change in RDY TTM EBITDA?
RDY TTM EBITDA is down -40.79% year-over-year
How far is RDY TTM EBITDA from its all-time high?
RDY TTM EBITDA is currently -40.99% below its historical high of $1.02B set on March 31, 2025
How does RDY TTM EBITDA rank versus sector peers?
RDY TTM EBITDA is higher than 90.99% of companies in Healthcare sector
When is RDY next earnings release?
The next earnings release for RDY is on
EBITDA Formula
EBITDA = Net Income + + +
Data Sources & References
- RDY Official Website www.drreddys.com
- RDY Profile on Yahoo Finance finance.yahoo.com/quote/RDY
- RDY Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/rdy